137 related articles for article (PubMed ID: 18652401)
1. [Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer].
Milano G
Rev Prat; 2008 May; 58(10):1056-9. PubMed ID: 18652401
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of colorectal cancer prevention and treatment.
Nguyen H; Tran A; Lipkin S; Fruehauf JP
Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics in chemotherapy of colorectal cancer.
Henriette Tanja L; Guchelaar HJ; Gelderblom H
Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.
Russo A; Corsale S; Cammareri P; Agnese V; Cascio S; Di Fede G; Macaluso M; Bazan V
J Cell Physiol; 2005 Sep; 204(3):742-9. PubMed ID: 15828025
[TBL] [Abstract][Full Text] [Related]
5. What is the role and impact of molecular markers on treatment decisions for colorectal cancer in the adjuvant setting?
Al-Salama HM; Johnstone EC; Kerr DJ
Discov Med; 2009 Oct; 8(42):104-7. PubMed ID: 19833054
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer therapeutics and the challenges of applied pharmacogenomics.
Kruzelock RP; Short W
Curr Probl Cancer; 2007; 31(5):315-66. PubMed ID: 17905192
[No Abstract] [Full Text] [Related]
7. Pharmacogenomics and -genetics in colorectal cancer.
Pohl A; Lurje G; Manegold PC; Lenz HJ
Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
[TBL] [Abstract][Full Text] [Related]
8. [Role of pharmacogenetics in chemotherapy of colorectal cancers].
Ceppa F; Fontan E; Cremades S; Bihannic R; Bousquet A; Beauvillain L; Burnat P
Rev Med Interne; 2007 Sep; 28(9):594-602. PubMed ID: 17624636
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer.
Moradi-Marjaneh R; Khazaei M; Seifi S; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2018; 24(23):2710-2718. PubMed ID: 30051785
[TBL] [Abstract][Full Text] [Related]
10. Promising new agents for treatment of patients with colorectal cancer.
Von Hoff DD
Semin Oncol; 1998 Oct; 25(5 Suppl 11):47-52. PubMed ID: 9786316
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of pharmacogenetics in gastrointestinal diseases.
Saito YA; Camilleri M
Expert Opin Pharmacother; 2006 Oct; 7(14):1857-69. PubMed ID: 17020413
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of colorectal cancer.
Marsh S
Expert Opin Pharmacother; 2005 Dec; 6(15):2607-16. PubMed ID: 16316300
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic contribution to drug response.
Watson RG; McLeod HL
Cancer J; 2011; 17(2):80-8. PubMed ID: 21427551
[TBL] [Abstract][Full Text] [Related]
14. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
15. Applications of genomic tools to colorectal cancer therapeutics.
Auman JT; McLeod HL
Curr Opin Mol Ther; 2008 Dec; 10(6):548-54. PubMed ID: 19051132
[TBL] [Abstract][Full Text] [Related]
16. The role of pharmacogenetics in the new ESMO colorectal cancer guidelines.
Schirripa M; Procaccio L; Lonardi S; Loupakis F
Pharmacogenomics; 2017 Feb; 18(3):197-200. PubMed ID: 28112993
[No Abstract] [Full Text] [Related]
17. CYP450 pharmacogenetics for personalizing cancer therapy.
van Schaik RH
Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
[TBL] [Abstract][Full Text] [Related]
18. Interpreting disparate responses to cancer therapy: the role of human population genetics.
Maitland ML; DiRienzo A; Ratain MJ
J Clin Oncol; 2006 May; 24(14):2151-7. PubMed ID: 16682733
[TBL] [Abstract][Full Text] [Related]
19. Developing novel and highly effective new therapeutic strategies for treatment of colorectal cancer: where do we go from here?
Houghton JA
Curr Opin Investig Drugs; 2001 May; 2(5):674-6. PubMed ID: 11569946
[No Abstract] [Full Text] [Related]
20. Pharmacogenetic aspects in treatment of colorectal cancer--an update.
Stoehlmacher J; Goekkurt E; Lenz HJ
Pharmacogenomics; 2003 Nov; 4(6):767-77. PubMed ID: 14596640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]